Latest Biotech News

Moffitt Cancer Center has secured a $22.4 million grant from the U.S. Department of War dedicated to research and clinical trials on leptomeningeal disease, a serious complication from cancer...

The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their discovery of regulatory T cells (Tregs), a critical mechanism of...

MapLight Therapeutics, developing CNS-targeted drugs including a schizophrenia medication poised to compete with Bristol Myers Squibb's Cobenfy, is pushing forward with IPO plans amid a U.S....

Insilico Medicine unveiled LEGION, an AI-driven drug discovery workflow covering vast chemical space around the NLRP3 inflammation target. This platform seeks to optimize new compound...

Dublin-based Aerska, focused on RNA interference therapeutics for neurological diseases, raised $21 million in a seed financing round. The company’s antibody-oligonucleotide conjugate platform...

Trogenix Ltd., emerging from stealth mode, secured $95 million in Series A funding to propel its pipeline into clinical trials, focusing on a novel “Trojan horse” gene therapy approach targeting...

Bioinformatics company Golden Helix received a $2.2 million NIH Phase II SBIR grant to advance its VSPGx pharmacogenomics interpretation software. The platform analyzes next-generation sequencing...

Fujirebio Diagnostics obtained FDA clearance for the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio Test, the first blood-based FDA-approved in vitro diagnostic for Alzheimer’s disease. This...

Skye Bioscience’s peripherally restricted CB1 receptor inhibitor nimacimab failed to meet the primary endpoint in a 26-week Phase 2a trial for weight loss monotherapy in overweight and obese...

Researchers at Lund University identified SLAMF6, a surface protein expressed on acute myeloid leukemia (AML) cells that functions as an immune evasion mechanism by suppressing T cell attack....

Researchers have developed new biodegradable, non-toxic solid lubricants derived from cellulose as an environmentally friendly alternative to talc and microplastic lubricants widely used in seed...

The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their seminal work on regulatory T cells (Tregs) and their role in peripheral...

Skye Bioscience announced topline results from its Phase 2a CBeyond trial evaluating nimacimab, a peripherally restricted CB1 inhibitor antibody, for weight loss. As monotherapy, nimacimab failed...

AstraZeneca and San Francisco-based biotech Algen Biotechnologies announced a collaboration worth up to $555 million to accelerate immunology drug discovery. Algen will apply its AlgenBrain...

Regencell Bioscience Holdings, an early-stage biotech focused on Traditional Chinese Medicine treatments for neurodevelopmental disorders, witnessed an unprecedented stock surge of over 64,000% in...

Scientists at IBEC and West China Hospital developed a novel bioactive nanoparticle therapy that restores blood-brain barrier (BBB) function, promoting clearance of amyloid-β (Aβ) plaques central...

Dublin-based biotech Aerska has emerged from stealth mode with $21 million in seed funding to develop antibody-oligonucleotide conjugates (AOCs) designed to deliver RNA interference therapies...

Asimov announced its AAV Edge Stable Producer system, generating stable HEK293 cell lines that integrate all necessary viral genes for adeno-associated virus (AAV) production, overcoming...

Researchers at Lund University identified SLAMF6, a surface protein expressed on approximately 60% of acute myeloid leukemia (AML) cases, which acts as an immune-suppressive shield enabling...

The FDA has launched a pilot program to speed regulatory review of generic drugs manufactured in the U.S. using domestically sourced active pharmaceutical ingredients (APIs). This initiative aims...